National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A05AA04	OCALIVA	B	Obeticholic acid - 10mg	10mg	Tablet, film coated	224,503,943 L.L
A05AA04	OCALIVA	B	Obeticholic acid - 5mg	5mg	Tablet, film coated	224,503,943 L.L
L04AA36	OCREVUS	BioTech	Ocrelizumab - 300mg/10ml	300mg/10ml	Injectable concentrate for solution	547,517,314 L.L
L04AA36	OCREVUS	BioTech	Ocrelizumab - 920mg/23ml	920mg/23ml	Injectable solution	1,095,034,629 L.L
L04AA36	OCREVUS	BioTech	Ocrelizumab - 300mg/10ml	300mg/10ml	Injectable concentrate for solution	L.L
J06BA02	OCTAGAM	BioHuman	Human normal immunoglobulin G - 50mg/ml	2.5g/50ml	Injectable solution	19,540,934 L.L
J06BA02	OCTAGAM	BioHuman	Human normal immunoglobulin G - 50mg/ml	5g/100ml	Injectable solution	37,672,334 L.L
J06BA02	OCTAGAM	BioHuman	Human normal immunoglobulin G - 50mg/ml	10g/200ml	Injectable solution	74,515,099 L.L
J06BA02	OCTAGAM 10%	BioHuman	Human normal immunoglobulin G - 10%	5g/50ml	Injectable solution	37,672,334 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
B02BD04	OCTANINE F	BioHuman	Plasma coagulation factor IX, human - 500IU	500IU	Injectable freeze dried powder + diluent	31,425,075 L.L
B02BD01	OCTAPLEX	BioHuman	Prothrombin complex, human (PPSB) - 500IU	500IU	Injectable powder for solution+diluent	35,220,164 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	880,217 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	952,784 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
L01EX09	OFEV	B	Nintedanib - 100mg	100mg	Capsule, soft	104,970,726 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	209,943,871 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	L.L
J01MA01	OFLACIN	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	602,041 L.L
S02AA16	OFLOMED	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	317,403 L.L
J01MA01	OFLOMED	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	601,530 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
L01FD01	OGIVRI	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	80,027,615 L.L
N05AH03	OLANZAMED	G	Olanzapine - 5mg	5mg	Tablet	665,522 L.L
N05AH03	OLANZAMED	G	Olanzapine - 20mg	20mg	Tablet	3,941,938 L.L
N05AH03	OLANZAMED	G	Olanzapine - 10mg	10mg	Tablet	902,294 L.L

...